Nilogen expands its business development and translational team

Tampa, Florida – January 20, 2021 — Nilogen Oncosystems today announces the appointment of several new team members to support our client programs across the US and beyond.

Laura Lockwood has joined Nilogen as our Director Business Development-West, covering the western half of the USA. Laura brings her considerable experience with Biotechnology and Pharmaceutical companies, providing expert services to help them translate their oncology candidates into the clinic.

Bonnie Phillips has joined Nilogen as our Associate Director of Translational Applications, working with our clients world-wide. Bonnie utilises her background and expertise in immunology, oncology, and biomarker panel design to help our clients develop studies that truly meet their needs.

“I am excited to welcome Laura and Bonnie to Nilogen” said Jon Waterman-Smith, VP of Business Development and Marketing at Nilogen. “With their wealth of experience working with clients in oncology drug development, the team will ensure that Nilogen develops and delivers studies that meets our client’s needs”.
Nilogen continues to see consistent growth year-on-year in clients and projects, providing the unique 3D-EXplore platform for oncology drug development capturing response, mechanism of action and biomarkers for chemotherapeutic and targeted therapies, monoclonal antibodies including bi and trispecifics, ADCS, ADCCs, Cellular Therapies and Oncolytic Virus. “Our new initiatives to expand the use of 3D-EXplore in Translational Studies globally are now underway, and we expect to make further announcements over the coming months about our growing global reach” said Jon.

Media Enquiries:
Jon Waterman-Smith